Visualitza per autoria "Guedea, Ferrán"

Ordena per: Ordre: Resultats:

  • Association between EBRT dose volume histograms and quality of life in prostate cancer patients
    Boladeras, Ana; Ferrer, Ferran; Navarro, Valentin; Blas, Rodolfo de; Cunillera, Oriol; Mateo, David; Gutiérrez, Cristina; Martínez, Evelyn; Villà, Salvador; Pera, Joan; Boladeras, Ana; Guedea, Ferrán (Elsevier, 2018)
    AIM: To evaluate the association between dose-volume histogram (DVH) values in organs at risk (OAR) and patient-reported HRQoL outcomes. BACKGROUND: Data on the association between DVHs and health-related quality of life ...
  • Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
    Henríquez Hernández, Luis Alberto; Valenciano, Almudena; Foro Arnalot, Palmira; Álvarez Cubero, María Jesús; Cozar, José Manuel; Suárez Novo, José Francisco; Castells Esteve, Manel; Fernández Gonzalo, Pablo; De-Paula Carranza, Belén; Ferrer Forés, Maria Montserrat; Guedea, Ferrán; Sancho-Pardo, Gemma; Craven-Bartle, Jordi; Ortiz Gordillo, María José; Cabrera Roldán, Patricia; Rodríguez Melcón, Juan Ignacio; Herrera Ramos, Estefanía; Rodríguez Gallego, Carlos; Lara, Pedro C. (Nature publishing group, 2016)
    BACKGROUND: Novel predictors of prognosis and treatment response for prostate cancer (PCa) are required to better individualize treatment. Single-nucleotide polymorphisms (SNPs) in four genes directly (XRCC5 (X-ray repair ...
  • Comparative effectiveness research in localized prostate cancer: a 10-year follow-up cohort study
    Garin Boronat, Olatz, 1979-; Suárez Novo, José Francisco; Guedea, Ferrán; Pont Acuña, Àngels; Pardo Cladellas, Yolanda; Goñi, Alai; Mariño, Alfonso; Hervás, Asunción; Herruzo, Ismael; Cabrera Roldán, Patricia; Sancho-Pardo, Gemma; Ponce de León, Javier; Macías, Víctor; Gutiérrez, Cristina; Castells Esteve, Manel; Ferrer Forés, Maria Montserrat; Multicentric Spanish Group of Clinically Localized Prostate Cancer (Elsevier, 2021)
    Purpose: Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and evidence is lacking especially for brachytherapy. The aim of this study was to assess the long-term impact of the ...
  • Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study
    Martínez, Evelyn; Garin Boronat, Olatz, 1979-; Pardo Cladellas, Yolanda; Fernández, Pablo; Guix, Benjamin; Gutiérrez, Cristina; Boladeras, Ana; Ferrer, Ferran; Hernández, Tania; Ayala, Adriana; Egiguren, Mikel; Fernández, Gema; Muñoz, Víctor; Macías, Víctor; Pera, Joan; Pont Acuña, Àngels; Ferrer Forés, Maria Montserrat; Guedea, Ferrán (Termedia Publishing, 2021)
    Introduction: Brachytherapy (BT) and external beam radiation therapy (EBRT) are effective treatments for high-risk prostate cancer (PCa). However, the impact of these treatments on health-related quality of life (HRQL) ...
  • Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study.
    Henríquez Hernández, Luis Alberto; Valenciano, Almudena; Foro Arnalot, Palmira; Álvarez Cubero, María Jesús; Cozar, José Manuel; Suárez Novo, José Francisco; Castells Esteve, Manel; Fernández Gonzalo, Pablo; De-Paula Carranza, Belén; Ferrer Forés, Maria Montserrat; Guedea, Ferrán; Sancho-Pardo, Gemma; Craven-Bartle, Jordi; Ortiz Gordillo, María José; Cabrera Roldán, Patricia; Rodríguez Melcón, Juan Ignacio; Herrera Ramos, Estefanía; Rodríguez Gallego, Carlos; Lara, Pedro C. (Elsevier, 2015)
    BACKGROUND: Prostate cancer (PCa) is an androgen-dependent disease. Nonetheless, the role of single nucleotide polymorphisms (SNPs) in genes encoding androgen metabolism remains an unexplored area. PURPOSE: To investigate ...
  • Intraethnic variation in steroid-5-alpha-reductase polymorphismsin prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
    Henríquez Hernández, Luis Alberto; Valenciano, Almudena; Foro Arnalot, Palmira; Álvarez Cubero, María Jesús; Cozar, José Manuel; Suárez Novo, José Francisco; Castells Esteve, Manel; Fernández Gonzalo, Pablo; De-Paula Carranza, Belén; Ferrer Forés, Maria Montserrat; Guedea, Ferrán; Sancho-Pardo, Gemma; Craven-Bartle, Jordi; Ortiz Gordillo, María José; Cabrera Roldán, Patricia; Herrera Ramos, Estefanía; Rodríguez Gallego, Carlos; Lara, Pedro C. (Springer Verlag, Indian Academy of Sciences, 2015)
  • Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study
    Suárez Novo, José Francisco; Zamora, Víctor; Garin Boronat, Olatz, 1979-; Gutiérrez, Cristina; Pont Acuña, Àngels; Pardo Cladellas, Yolanda; Goñi, Alai; Mariño, Alfonso; Hervás, Asunción; Herruzo, Ismael; Cabrera Roldán, Patricia; Sancho-Pardo, Gemma; Ponce de León, Javier; Macías, Víctor; Guedea, Ferrán; Vigués, Francesc; Castells, Manuel; Ferrer Forés, Maria Montserrat; Multicentric Spanish Group of Clinically Localized Prostate Cancer (Nature Research, 2022)
    To compare the effectiveness at ten years of follow-up of radical prostatectomy, brachytherapy and external radiotherapy, in terms of overall survival, prostate cancer-specific mortality and biochemical recurrence. Cohort ...
  • Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies
    Henríquez Hernández, Luis Alberto; Valenciano, Almudena; Foro Arnalot, Palmira; Álvarez Cubero, María Jesús; Cozar, José Manuel; Suárez Novo, José Francisco; Castells Esteve, Manel; Ayala-Gil, Adriana; Fernández Gonzalo, Pablo; Ferrer Forés, Maria Montserrat; Guedea, Ferrán; Sancho-Pardo, Gemma; Craven-Bartle, Jordi; Ortiz Gordillo, María José; Cabrera Roldán, Patricia; Herrera Ramos, Estefanía; Lara, Pedro C. (Public Library of Science (PLoS), 2013)
    Background: Differences in the distribution of genotypes between individuals of the same ethnicity are an important confounder factor commonly undervalued in typical association studies conducted in radiogenomics. Objective: ...
  • Relief of urinary symptom burden after primary prostate cancer treatment.
    Chang, Peter; Regan, Meredith M.; Ferrer, Montserrat; Guedea, Ferrán; Patil, Dattatraya; Wei, John T.; Hembroff, Larry A.; Michalski, Jeff M.; Saigal, Chris S.; Litwin, Mark S.; Hamstra, Daniel A.; Kaplan, Irving D.; Ciezki, Jay P.; Klein, Eric A.; Kibel, Adam S.; Sandler, Howard M.; Dunn, Rodney L.; Crociani, Catrina M.; Sanda, Martin George; PROST-QA Consortium (Elsevier, 2017)
    PURPOSE: Harms of prostate cancer treatment on urinary health related quality of life have been thoroughly studied. In this study we evaluated not only the harms but also the potential benefits of prostate cancer treatment ...
  • Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression
    Henríquez Hernández, Luis Alberto; Valenciano, Almudena; Foro Arnalot, Palmira; Álvarez Cubero, María Jesús; Cozar, José Manuel; Suárez Novo, José Francisco; Castells Esteve, Manel; Fernández Gonzalo, Pablo; De-Paula Carranza, Belén; Ferrer Forés, Maria Montserrat; Guedea, Ferrán; Sancho-Pardo, Gemma; Craven-Bartle, Jordi; Ortiz-Gordillo, María José; Cabrera Roldán, Patricia; Herrera Ramos, Estefanía; Rodríguez Gallego, Carlos; Rodríguez Melcón, Juan Ignacio; Lara, Pedro C. (BioMed Central, 2014)
    Background: Besides serum levels of PSA, there is a lack of prostate cancer specific biomarkers. It is need to develop new biological markers associated with the tumor behavior which would be valuable to better individualize ...
  • Subclinical left ventricular dysfunction detected by speckle-tracking echocardiography in breast cancer patients treated with radiation therapy: a six-month follow-up analysis (MEDIRAD EARLY-HEART study)
    Locquet, Médéa; Spoor, Daan; Crijns, Anne; van der Harst, Pim; Eraso, Arantxa; Guedea, Ferrán; Fiuza, Manuela; Santos, Susana Constantino Rosa; Combs, Stephanie; Borm, Kai; Mousseaux, Elie; Gencer, Umit; Frija, Guy; Cardis, Elisabeth; Langendijk, Hans; Jacob, Sophie (Frontiers, 2022)
    Background: In the case of breast cancer (BC), radiotherapy (RT) helps reduce locoregional recurrence and BC-related deaths but can lead to cardiotoxicity, resulting in an increased risk of long-term major cardiovascular ...

Cerca

Visualitza

El meu compte

Amb col·laboració de Complim Participem